AutoDELFIA Neonatal immunoreactive trypsin(ogen) (IRT) kit, intended for the quantitative determi...
FDA Device Recall #Z-1220-2018 — Class III — September 25, 2017
Recall Summary
| Recall Number | Z-1220-2018 |
| Classification | Class III — Low risk |
| Date Initiated | September 25, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | PerkinElmer Life and Analytical Sciences, Wallac, OY |
| Location | Turku, N/A |
| Product Type | Devices |
| Quantity | 240 |
Product Description
AutoDELFIA Neonatal immunoreactive trypsin(ogen) (IRT) kit, intended for the quantitative determination of human immunoreactive trypsin(ogen) (IRT) in blood specimens. (UDI: (01)06438147298716(17)190430(10)656479); Product Number: B005-212
Reason for Recall
The Quality Control Certificate for certain AutoDELFIA Neonatal IRT Kits is missing information required to assess the acceptability of measured control values which may result in a delay in reporting IRT results.
Distribution Pattern
Distributed to CT and TX.
Lot / Code Information
Lot Number: 656479, Batch Number: 1065647901, Expiration date: 2019-4-30
Other Recalls from PerkinElmer Life and Analytical Scien...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1239-2019 | Class II | AutoDELFIA¿ hCG Kit, In Vitro Diagnostic for th... | Jan 10, 2019 |
| Z-1237-2019 | Class II | DELFIA¿ hCG Kit, In Vitro Diagnostic for the de... | Jan 10, 2019 |
| Z-1238-2019 | Class II | AutoDELFIA¿ hCG Kit, In Vitro Diagnostic for th... | Jan 10, 2019 |
| Z-1541-2018 | Class II | Specimen Gate Screening Center, Part Number 500... | Nov 17, 2017 |
| Z-1692-2018 | Class II | NeoBase Succinylacetone Assay Solution, Product... | Nov 2, 2017 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.